Published in Acta Biomater on August 13, 2010
Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly. Tissue Eng Part B Rev (2012) 0.92
Photo-active collagen systems with controlled triple helix architecture. J Mater Chem B Mater Biol Med (2013) 0.79
Advances in biomimetic regeneration of elastic matrix structures. Drug Deliv Transl Res (2012) 0.78
The elastic fiber. I. The separation and partial characterization of its macromolecular components. J Cell Biol (1969) 4.51
Signaling properties of hyaluronan receptors. J Biol Chem (2001) 3.95
Elastin is an essential determinant of arterial morphogenesis. Nature (1998) 3.56
Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules (2005) 3.44
Functions of hyaluronan in wound repair. Wound Repair Regen (1999) 3.11
CD44 cell adhesion molecules. Mol Pathol (1999) 2.89
Physicochemical foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng (2000) 2.73
Extracellular matrix 4: the elastic fiber. FASEB J (1993) 2.28
Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng (2003) 2.17
New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res (1999) 1.86
Elastin structure, biosynthesis, and relation to disease states. N Engl J Med (1981) 1.78
Three-dimensional tissue fabrication. Adv Drug Deliv Rev (2004) 1.76
Hyaluronan: Preparation, Structure, Properties, and Applications. Chem Rev (1998) 1.71
Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release (2000) 1.59
Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci (1991) 1.57
The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem (2001) 1.55
Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem (2001) 1.41
Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol (1994) 1.39
Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J (1993) 1.38
Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A (2004) 1.37
Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials (2001) 1.35
New insights into elastin and vascular disease. Trends Cardiovasc Med (2003) 1.32
Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes. Br J Ophthalmol (1986) 1.32
The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol (2005) 1.29
Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials (2005) 1.20
Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells. Biomaterials (2006) 1.19
Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials (2006) 1.15
A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules (2000) 1.15
Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials (2005) 1.14
The CD44 protein family. Int J Biochem Cell Biol (1998) 1.14
Hyaluronan-based scaffolds (Hyalograft C) in the treatment of knee cartilage defects: preliminary clinical findings. Novartis Found Symp (2003) 1.10
Immunocytochemical localization of proteoglycans within normal elastin fibers. Eur J Cell Biol (1990) 1.09
The synthesis of elastin, collagen, and glycosaminoglycans by high density primary cultures of neonatal rat aortic smooth muscle. An ultrastructural and biochemical study. Eur J Cell Biol (1982) 1.07
Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res (2000) 1.07
Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv (2005) 1.07
Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas. J Cell Biol (1987) 1.03
Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol (1999) 1.00
Ultraviolet light-induced modification of crosslinked hyaluronan gels. J Biomed Mater Res A (2003) 0.96
Smooth muscle cell adhesion on crosslinked hyaluronan gels. J Biomed Mater Res (2002) 0.92
Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells. Biomaterials (2007) 0.92
Assessment of the cytotoxicity of photocrosslinked dextran and hyaluronan-based hydrogels to vascular smooth muscle cells. Biomaterials (2002) 0.90
Structural and rheological characterization of hyaluronic acid-based scaffolds for adipose tissue engineering. Biomaterials (2007) 0.90
The elastin-laminin receptor functions as a mechanotransducer in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2001) 0.87
In vivo regeneration of small-diameter (2 mm) arteries using a polymer scaffold. FASEB J (2005) 0.85
High hyaluronic acid and low dermatan sulfate contents in human pulmonary arteries compared to in the aorta. Blood Vessels (1988) 0.82
Hyaluronic acid--a versatile biopolymer. Aust J Biotechnol (1990) 0.80
Formation of defined microporous 3D structures starting from cross-linked hydrogels. J Biomed Mater Res B Appl Biomater (2004) 0.80
Elastin and vascular disease. Trends Cardiovasc Med (2011) 0.78
Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells. Biomaterials (2007) 0.92
Animal models of osteomyelitis. Int J Artif Organs (2006) 0.91
Automated ribotyping to distinguish the different non Sau/ non Sep staphylococcal emerging pathogens in orthopedic implant infections. Int J Artif Organs (2006) 0.77
Biocompatibility of supercritical CO2-treated titanium implants in a rat model. Int J Artif Organs (2006) 0.75